Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting? [electronic resource]
Producer: 20060522Description: 135-49 p. digitalISSN:- 1049-9091
- Algorithms
- Anti-Anxiety Agents -- administration & dosage
- Antiemetics -- administration & dosage
- Cohort Studies
- Dose-Response Relationship, Drug
- Evidence-Based Medicine
- Female
- Fentanyl -- economics
- Hospice Care -- economics
- Humans
- Hypnotics and Sedatives -- administration & dosage
- Male
- Narcotics -- economics
- Nausea -- drug therapy
- Ondansetron -- economics
- Pain -- drug therapy
- Pharmaceutical Services -- organization & administration
- Prochlorperazine -- economics
- Pyridines -- economics
- Retrospective Studies
- Sleep Initiation and Maintenance Disorders -- drug therapy
- Southeastern United States
- Temazepam -- economics
- Zolpidem
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.